| 摘要 |
The invention relates to a pharmaceutical preparation that contains at least 4-[4-(3-chloro-4-methoxy-benzylamino)-benzo[4,5]thieno[2,3-d]pyrimidine-2-yl]-cyclohexane carboxylic acid or one of its pharmaceutically acceptable salts thereof and/or 4-[4-(3-chloro-4-hydroxy-benzylamino)-benzo[4,5]thieno[2,3-d]pyrimidine-2-yl]-cyclohexane carboxylic acid or one of its pharmaceutically acceptable salts, an excipient, a disintegrant and optionally a flow regulator. |
